Patent · US Active

Compositions and methods for modulation of LMNA expression

US9856473B2 · kind B2 · utility

1Cited by
10References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2014
Grant dateJan 2, 2018
Priority date
Expiry dateJun 25, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/33
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed herein are compounds, compositions and methods for modulating the expression of LMNA in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Further provided are methods of identifying cis splicing regulatory elements of a selected mRNA using the disclosed compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.